EUVIMEDEUVIMED entdecken
Crossref

Microbiota-Mediated Modulation of Chemotherapeutic Drug Efficacy in Colorectal Cancer: An In-Depth Analysis of Six Key Drugs

Priyanka Dalal, Nandini Bajaj, Uttkarsh Katiyar, Deepika Sharma iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c00587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Priyanka Dalal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nano Science and Technology, Mohali, Punjab 140306, India. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Antineoplastic Agents, Gastrointestinal Microbiome. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Institute of Nano Science and Technology, University Grants Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) remains a major health burden, and emerging evidence suggests that gut microbiota may influence therapeutic responses. This study explores the interaction between Escherichia coli and non-CRC-specific anticancer drugs cyclophosphamide, Cytalon, Nitrol, etoposide, gemcitabine, and methotrexate through bacterial modification. Following bacterial incubation, drugs were tested in vitro using MTT and Alamar Blue assays, revealing significantly enhanced cytotoxicity against CRC cells (HCT116) while preserving variability in normal fibroblasts (L929). Mechanistic studies, including ROS production, mitochondrial membrane potential loss, cell cycle arrest, NF-κB translocation, and TNF-α activation confirmed the cell death induction. NMR analysis and 3D spheroid disruption demonstrated structural drug alterations postincubation in one of the best-responding drugs. These findings highlight microbial drug transformation as a promising avenue for enhancing chemotherapeutic selectivity and efficacy in colorectal cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAntineoplastic AgentsGastrointestinal MicrobiomeHumansHCT116 CellsEscherichia coliMembrane Potential, MitochondrialReactive Oxygen SpeciesNF-kappa BMiceAnimalsMethotrexateCell Line, TumorGemcitabineTumor Necrosis Factor-alphaDeoxycytidineCell Cycle Checkpoints

Stichwörter der Autor:innen

Chemotherapeutic drugColorectal cancerCytalonDrug modificationEscherichia coliMicrobiota

Substanzen

Antineoplastic AgentsReactive Oxygen SpeciesNF-kappa BMethotrexateGemcitabineTumor Necrosis Factor-alphaDeoxycytidine

Autor:innen und Institutionen

  • Institute of Nano Science and Technology, Mohali, Punjab 140306, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India.

ORCID-Profile: Deepika Sharma

Förderung

  • Institute of Nano Science and Technology
  • University Grants Commission

Zitieren

APA

Dalal, P., Bajaj, N., Katiyar, U., & Sharma, D. (2025). Microbiota-Mediated Modulation of Chemotherapeutic Drug Efficacy in Colorectal Cancer: An In-Depth Analysis of Six Key Drugs. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00587

Vancouver

Dalal P, Bajaj N, Katiyar U, Sharma D. Microbiota-Mediated Modulation of Chemotherapeutic Drug Efficacy in Colorectal Cancer: An In-Depth Analysis of Six Key Drugs. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00587

BibTeX
@article{Dalal2025,
  author = {Dalal, Priyanka and Bajaj, Nandini and Katiyar, Uttkarsh and Sharma, Deepika},
  title = {Microbiota-Mediated Modulation of Chemotherapeutic Drug Efficacy in Colorectal Cancer: An In-Depth Analysis of Six Key Drugs},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c00587}
}
Kostenlos starten →